Cardiac Resynchronization Therapy Devices (CRT)

August 11, 2014 — Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators (CRT-...

The U.S. Food and Drug Administration (FDA) approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers (CRT-P) and eight cardiac resynchronization defibrillators (CRT-D), expanding the indication for u...

Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D). Medtronic CRT devices...

ICD, MADIT-CRT trial, long-term followup, ACC.14

Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable cardioverter defibrillator (ICD), according to research...

Medtronic Viva Quad XT CRT-D Adaptiv CRT
August 11, 2014 — Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and...
May 14, 2014 — Data presented during Heart Rhythm 2014 found the use of quadripolar leads reduced the number of hospitalizations by 53 percent when...
Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac...
Medtronic Viva Quad XT CRT-D Adaptiv CRT
Medtronic received U.S. Food and Drug Administration (FDA) approval for the Attain Performa model 4298 quadripolar lead, and the Viva Quad
Cook Medical customers in the United States again have access to its Evolution RL and Evolution Shortie RL controlled-rotation dilator...
The Spectranetics Corp.'s portfolio includes two mechanical lead extraction platforms that expand physicians' options for the safe removal...
The Optisure defibrillation lead is an addition to St. Jude Medical's Optim lead family, joining the Durata defibrillation lead. Based...

Articles

May 14, 2014 — Data presented during Heart Rhythm 2014 found the use of quadripolar leads reduced the number of hospitalizations by 53 percent when...
Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac...
ICD, MADIT-CRT trial, long-term followup, ACC.14
Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with...
Boston scientific autogen x4 crt-d crt ICD heart failure cardiac
Boston Scientific Corp. has received CE mark approval of its X4 line of quadripolar cardiac resynchronization therapy defibrillator (CRT-D) systems,...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
4 weeks 2 hours ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
6 weeks 1 day ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
7 weeks 1 day ago
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live...